Flumazenil subcutaneous - Bexson Biomedical
Alternative Names: BB-20XLatest Information Update: 04 Aug 2022
At a glance
- Originator Bexson Biomedical
- Class Antidotes; Benzodiazepinones; Esters; Fluorine compounds; Imidazoles; Small molecules
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Substance-related disorders
Most Recent Events
- 19 Jul 2022 Preclinical trials in Substance-related disorders in USA (SC)